RLMD Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 117843 min ago

@ $5.51

Wydano: 14 vas. 2024 @ 22:13

Zwrot: -30.13%

Poprzedni sygnał: vas. 14 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: 2.99 %

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 19:14):

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders...

Stats
Dzisiejszy wolumen	35 959.00
Średni wolumen	183 121
Kapitalizacja rynkowa	116.17M
EPS	$0 ( 2024-03-19 )
Następna data zysków	( $-0.900 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.170
ATR14	$0.0140 (0.36%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-31	Traversa Sergio	Buy	27 460	Common Stock
2024-01-30	Traversa Sergio	Buy	40 999	Common Stock
2024-01-29	Traversa Sergio	Buy	31 541	Common Stock
2024-01-31	Shenouda Maged	Buy	6 875	Common Stock
2024-01-30	Shenouda Maged	Buy	15 000	Common Stock

INSIDER POWER
66.71
Last 97 transactions
Buy: 7 635 369 \| Sell: 1 906 109

Wolumen Korelacja

Długi: -0.01 (neutral)

Krótki: 0.91 (very strong)

Signal:(54.757) Expect same movement, but be aware

Relmada Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
TCRT	0.953
WISA	0.929
TTCF	0.925
MDVL	0.919
PCVX	0.917
VSTA	0.915
QTEK	0.914
VIRX	0.914
FNCH	0.913
AVO	0.912

10 Najbardziej negatywne korelacje
SLGN	-0.904
STAY	-0.904
MGI	-0.903
WEN	-0.903
CCRC	-0.903
IBEX	-0.9
IMMR	-0.899
ISIG	-0.898
MNKD	-0.88
NTUS	-0.878

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Relmada Therapeutics Inc Korelacja - Waluta/Towar

-0.42
( neutral )

-0.44
( neutral )

0.00
( neutral )

-0.03
( neutral )

0.40
( neutral )

0.13
( neutral )

Relmada Therapeutics Inc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-3.28

FY	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-3.28

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-5.30

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-8.06

Financial Reports:

No articles found.

Relmada Therapeutics Inc

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Aktualne aktualizacje dla Relmada Therapeutics Inc [RLMD]

Upcoming Earnings Alert